Cargando…
Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
Chemotherapy is the main treatment option for advanced osteosarcoma, which is the most common type of primary bone malignancy. However, patients develop resistance rapidly and many succumb to the disease. Niclosamide, an anthelmintic drug, has been recently identified to display potent and selective...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Genética
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897237/ https://www.ncbi.nlm.nih.gov/pubmed/36735625 http://dx.doi.org/10.1590/1678-4685-GMB-2022-0136 |